SPRO - Spero Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SPRO is currently covered by 3 analysts with an average price target of $9.34. This is a potential upside of $8.13 (671.9%) from yesterday's end of day stock price of $1.21.

Spero Therapeutics's activity chart (see below) currently has 18 price targets and 30 ratings on display. The stock rating distribution of SPRO is 92.86% BUY and 7.14% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 40.5 days.

Highest price target for SPRO is $5, Lowest price target is $5, average price target is $9.34.

Most recent stock forecast was given by LOUISE CHEN from CANTOR FITZGERALD on 15-Nov-2024.

Best performing analysts who are covering SPRO - Spero Therapeutics:

Kevin Degeeter Esther Hong Raghuram Selvaraju Louise Chen Josh Schimmer Ritu Baral

Currently out of the existing stock ratings of SPRO, 13 are a BUY (92.86%), 1 are a HOLD (7.14%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

2 days ago
(15-Nov-2024)

0/3 (0%)

$3.35 (203.03%)

Buy

$5

$3.79 (313.22%)

$7

13 days ago
(04-Nov-2024)

0/16 (0%)

$3.76 (303.23%)

Buy

$8

$6.79 (561.16%)

$2

2 years 1 months 25 days ago
(23-Sep-2022)

1/2 (50%)

$6.03 (306.09%)

2

Hold

$47

2 years 5 months 28 days ago
(20-May-2022)

0/1 (0%)

$28.64 (155.99%)

Buy

$21

3 years 1 months 17 days ago
(01-Oct-2021)

2/2 (100%)

$7.02 (60.23%)

241

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SPRO (Spero Therapeutics) average time for price targets to be met?

On average it took 40.5 days on average for the stock forecasts to be realized with a an average price target met ratio 25

Which analyst has the current highest performing score on SPRO (Spero Therapeutics) with a proven track record?

KEVIN DEGEETER

Which analyst has the current lower performing score on SPRO (Spero Therapeutics) with a proven track record?

RITU BARAL

Which analyst has the most public recommendations on SPRO (Spero Therapeutics)?

Kevin Degeeter has 7 price targets and 6 ratings on SPRO

Which analyst is the currently most bullish on SPRO (Spero Therapeutics)?

Josh Schimmer with highest potential upside - $6.79

Which analyst is the currently most reserved on SPRO (Spero Therapeutics)?

Esther Hong with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?